Integra LifeSciences Holdings ROA 2011-2025 | IART
Current and historical return on assets (ROA) values for Integra LifeSciences Holdings (IART) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Integra LifeSciences Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.50B | $3.65B | -12.85% |
| 2025-06-30 | $-0.50B | $3.67B | -12.66% |
| 2025-03-31 | $-0.03B | $4.05B | -0.71% |
| 2024-12-31 | $-0.01B | $4.04B | -0.17% |
| 2024-09-30 | $-0.01B | $4.07B | -0.15% |
| 2024-06-30 | $0.02B | $4.07B | 0.61% |
| 2024-03-31 | $0.04B | $4.08B | 1.04% |
| 2023-12-31 | $0.07B | $3.78B | 1.78% |
| 2023-09-30 | $0.10B | $3.74B | 2.64% |
| 2023-06-30 | $0.13B | $3.78B | 3.44% |
| 2023-03-31 | $0.17B | $3.74B | 4.53% |
| 2022-12-31 | $0.18B | $3.89B | 4.79% |
| 2022-09-30 | $0.17B | $3.81B | 4.61% |
| 2022-06-30 | $0.17B | $3.75B | 4.43% |
| 2022-03-31 | $0.16B | $3.67B | 4.18% |
| 2021-12-31 | $0.17B | $3.78B | 4.48% |
| 2021-09-30 | $0.22B | $3.77B | 5.82% |
| 2021-06-30 | $0.21B | $3.71B | 5.65% |
| 2021-03-31 | $0.17B | $3.74B | 4.79% |
| 2020-12-31 | $0.13B | $3.62B | 3.85% |
| 2020-09-30 | $0.06B | $3.45B | 1.65% |
| 2020-06-30 | $0.00B | $3.39B | -0.12% |
| 2020-03-31 | $0.03B | $3.45B | 0.78% |
| 2019-12-31 | $0.05B | $3.30B | 1.52% |
| 2019-09-30 | $0.06B | $3.35B | 1.85% |
| 2019-06-30 | $0.10B | $3.29B | 3.16% |
| 2019-03-31 | $0.08B | $3.21B | 2.59% |
| 2018-12-31 | $0.06B | $3.11B | 1.89% |
| 2018-09-30 | $0.08B | $3.18B | 2.46% |
| 2018-06-30 | $0.07B | $3.19B | 2.29% |
| 2018-03-31 | $0.07B | $3.25B | 2.51% |
| 2017-12-31 | $0.06B | $3.21B | 2.62% |
| 2017-09-30 | $0.05B | $2.42B | 2.29% |
| 2017-06-30 | $0.07B | $2.10B | 3.34% |
| 2017-03-31 | $0.07B | $2.05B | 3.57% |
| 2016-12-31 | $0.07B | $1.81B | 4.07% |
| 2016-09-30 | $0.06B | $1.83B | 3.37% |
| 2016-06-30 | $0.01B | $1.81B | 0.50% |
| 2016-03-31 | $0.00B | $1.83B | 0.06% |
| 2015-12-31 | $0.00B | $1.77B | -0.24% |
| 2015-09-30 | $0.00B | $1.83B | -0.12% |
| 2015-06-30 | $0.04B | $1.64B | 2.53% |
| 2015-03-31 | $0.04B | $1.55B | 2.56% |
| 2014-12-31 | $0.03B | $1.59B | 2.18% |
| 2014-09-30 | $0.03B | $1.55B | 2.12% |
| 2014-06-30 | $-0.01B | $1.56B | -0.66% |
| 2014-03-31 | $-0.01B | $1.56B | -0.94% |
| 2013-12-31 | $-0.02B | $1.19B | -1.69% |
| 2013-09-30 | $-0.02B | $1.18B | -1.79% |
| 2013-06-30 | $0.02B | $1.19B | 1.87% |
| 2013-03-31 | $0.03B | $1.16B | 2.49% |
| 2012-12-31 | $0.04B | $1.16B | 3.60% |
| 2012-09-30 | $0.03B | $1.19B | 2.92% |
| 2012-06-30 | $0.03B | $1.16B | 2.76% |
| 2012-03-31 | $0.02B | $1.16B | 2.07% |
| 2011-12-31 | $0.03B | $1.14B | 2.50% |
| 2011-09-30 | $0.04B | $1.18B | 3.86% |
| 2011-06-30 | $0.05B | $1.15B | 4.54% |
| 2011-03-31 | $0.06B | $1.01B | 6.21% |
| 2010-12-31 | $0.07B | $1.02B | 6.74% |
| 2010-09-30 | $0.06B | $0.96B | 6.56% |
| 2010-06-30 | $0.06B | $0.94B | 6.33% |
| 2010-03-31 | $0.06B | $0.94B | 5.90% |
| 2009-12-31 | $0.05B | $0.94B | 5.29% |
| 2009-09-30 | $0.06B | $0.97B | 5.89% |
| 2009-06-30 | $0.03B | $0.95B | 2.75% |
| 2009-03-31 | $0.03B | $1.00B | 2.91% |
| 2008-12-31 | $0.03B | $1.03B | 2.83% |
| 2008-09-30 | $0.00B | $0.96B | 0.22% |
| 2008-06-30 | $0.03B | $0.86B | 3.35% |
| 2008-03-31 | $0.03B | $0.97B | 3.08% |
| 2007-12-31 | $0.03B | $0.82B | 3.44% |
| 2007-09-30 | $0.04B | $0.81B | 5.38% |
| 2007-06-30 | $0.03B | $0.78B | 4.74% |
| 2007-03-31 | $0.03B | $0.62B | 4.99% |
| 2006-12-31 | $0.03B | $0.61B | 5.27% |
| 2006-09-30 | $0.03B | $0.60B | 5.88% |
| 2006-06-30 | $0.04B | $0.57B | 7.71% |
| 2006-03-31 | $0.04B | $0.49B | 8.18% |
| 2005-12-31 | $0.04B | $0.45B | 8.06% |
| 2005-09-30 | $0.04B | $0.47B | 7.80% |
| 2005-06-30 | $0.02B | $0.45B | 3.96% |
| 2005-03-31 | $0.02B | $0.47B | 4.00% |
| 2004-12-31 | $0.02B | $0.46B | 3.88% |
| 2004-09-30 | $0.02B | $0.44B | 3.74% |
| 2004-06-30 | $0.03B | $0.44B | 7.42% |
| 2004-03-31 | $0.03B | $0.42B | 6.87% |
| 2003-12-31 | $0.03B | $0.41B | 6.64% |
| 2003-09-30 | $0.04B | $0.40B | 11.76% |
| 2003-06-30 | $0.04B | $0.39B | 11.67% |
| 2003-03-31 | $0.04B | $0.36B | 12.98% |
| 2002-12-31 | $0.04B | $0.28B | 14.30% |
| 2002-09-30 | $0.03B | $0.24B | 12.02% |
| 2002-06-30 | $0.03B | $0.23B | 13.39% |
| 2002-03-31 | $0.03B | $0.23B | 15.34% |
| 2001-12-31 | $0.03B | $0.23B | 17.42% |
| 2001-09-30 | $0.00B | $0.21B | -2.51% |
| 2001-06-30 | $-0.01B | $0.09B | -5.59% |
| 2001-03-31 | $-0.01B | $0.09B | -9.41% |
| 2000-12-31 | $-0.01B | $0.09B | -14.86% |
| 2000-09-30 | $0.00B | $0.09B | -1.32% |
| 2000-06-30 | $-0.01B | $0.08B | -7.14% |
| 2000-03-31 | $-0.01B | $0.07B | -13.28% |
| 1999-12-31 | $-0.01B | $0.07B | -10.61% |
| 1999-09-30 | $-0.01B | $0.06B | -15.45% |
| 1999-06-30 | $-0.01B | $0.07B | -19.23% |
| 1999-03-31 | $-0.01B | $0.07B | -20.22% |
| 1998-12-31 | $-0.01B | $0.04B | -32.65% |
| 1998-09-30 | $-0.02B | $0.04B | -53.33% |
| 1998-06-30 | $-0.02B | $0.04B | -49.35% |
| 1998-03-31 | $-0.02B | $0.04B | -44.44% |
| 1997-12-31 | $-0.02B | $0.04B | -39.31% |
| 1997-09-30 | $-0.01B | $0.04B | -17.39% |
| 1997-06-30 | $-0.01B | $0.05B | -16.67% |
| 1997-03-31 | $-0.01B | $0.05B | -16.00% |
| 1996-12-31 | $-0.01B | $0.05B | -20.92% |
| 1996-09-30 | $-0.01B | $0.05B | -30.77% |
| 1996-06-30 | $-0.03B | $0.05B | -144.00% |
| 1996-03-31 | $-0.03B | $0.00B | -288.89% |
| 1995-12-31 | $-0.03B | $0.00B | -277.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.960B | $1.611B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.349B | 26.18 |
| Intuitive Surgical (ISRG) | United States | $205.110B | 80.25 |
| IDEXX Laboratories (IDXX) | United States | $56.892B | 56.50 |
| Edwards Lifesciences (EW) | United States | $49.418B | 33.14 |
| Alcon (ALC) | Switzerland | $38.157B | 25.79 |
| IQVIA Holdings (IQV) | United States | $37.216B | 20.75 |
| Mettler-Toledo (MTD) | United States | $29.520B | 34.54 |
| STERIS (STE) | Ireland | $26.176B | 27.02 |
| Waters (WAT) | United States | $22.989B | 30.41 |
| DexCom (DXCM) | United States | $22.672B | 31.25 |
| Hologic (HOLX) | United States | $16.592B | 17.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.147B | 0.00 |
| Globus Medical (GMED) | United States | $11.472B | 23.86 |
| Penumbra (PEN) | United States | $10.953B | 77.05 |
| Masimo (MASI) | United States | $7.879B | 25.25 |
| Sysmex ADR (SSMXY) | Japan | $6.616B | 21.02 |
| Glaukos (GKOS) | United States | $5.163B | 0.00 |
| Teleflex (TFX) | United States | $4.961B | 7.91 |
| TransMedics (TMDX) | United States | $4.174B | 49.45 |
| Veracyte (VCYT) | United States | $3.372B | 38.43 |
| Alphatec Holdings (ATEC) | United States | $3.078B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.877B | 15.54 |
| Integer Holdings (ITGR) | United States | $2.446B | 11.48 |
| Artivion (AORT) | United States | $2.220B | 101.87 |
| Nihon Kohden (NHNKY) | Japan | $1.815B | 15.84 |
| PROCEPT BioRobotics (PRCT) | United States | $1.751B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.710B | 16.57 |
| Beta Bionics (BBNX) | United States | $1.269B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.188B | 0.00 |
| AxoGen (AXGN) | United States | $1.128B | 0.00 |
| IRadimed (IRMD) | United States | $1.077B | 51.30 |
| Pulse Biosciences (PLSE) | United States | $1.038B | 0.00 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| SiBone (SIBN) | United States | $0.791B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.607B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.562B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.561B | 32.60 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.541B | 10.80 |
| AngioDynamics (ANGO) | United States | $0.520B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.495B | 0.00 |
| NeuroPace (NPCE) | United States | $0.449B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.442B | 12.20 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| RxSight (RXST) | United States | $0.421B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.414B | 3.25 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.334B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.312B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.71 |
| CVRx (CVRX) | United States | $0.258B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.214B | 0.00 |
| 908 Devices (MASS) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.139B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.53 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |